Dr. Pamela Kryskow is a medical doctor with a strong interest in psychedelic medicine, mental health and chronic pain.
Founding board members of the Canadian Psychedelic Association. She is part of an expert team working to give Canadians access to psilocybin at end of life.
Dr Kryskow is actively involved in research related to psilocybin, MDMA, ketamine, mental wellness and neurogenesis.
Co-investigator on the largest microdosing study Microdose.me which is ongoing with 14 000+ enrolled participants.
A Clinical Instructor at University of British Columbia and Adjunct Professor at Vancouver Island University.
The medical lead on the Roots To Thrive Ketamine Assisted Therapy program that treats health care providers with PTSD, depression, anxiety, and addiction.
In real life she loves foraging in the forest, ocean kayaking, growing kale and daydreaming in the hammock.